PRESS RELEASE published on 04/25/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués Sensorion annonce la participation du Dr. Natalie Loundon à la réunion annuelle de la Société américaine d'oto-rhino-laryngologie pédiatrique pour présenter la thérapie génique SENS-501 pour la perte auditive Thérapie Génique Sensorion Perte Auditive Dr. Natalie Loundon ASPO
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
BRIEF published on 04/18/2025 at 09:29, 1 year ago Sensorion prepares its General Meeting of May 12, 2025 Shareholders Biotechnology General Meeting Sensorion Hearing Loss
BRIEF published on 04/18/2025 at 09:29, 1 year ago Sensorion prépare son Assemblée générale du 12 mai 2025 Actionnaires Biotechnologie Assemblée Générale Sensorion Perte Auditive
PRESS RELEASE published on 04/18/2025 at 09:24, 1 year ago Inside Information / Other news releases Sensorion provides preliminary documents for the Combined Shareholders' General Meeting of May 12, 2025 at Hotel Square Louvois, Paris. Shareholders can request meeting documents and view details on company website Shareholders' Meeting General Meeting Preliminary Documents Sensorion Hearing Loss
PRESS RELEASE published on 04/18/2025 at 09:24, 1 year ago Informations privilégiées / Autres communiqués Sensorion annonce la mise à disposition des documents préparatoires pour son Assemblée générale mixte du 12 mai 2025. Consultation possible sur www.sensorion.com Biotechnologie Documents Préparatoires Assemblée Générale Mixte Sensorion Perte Auditive
BRIEF published on 04/16/2025 at 07:35, 1 year ago Sensorion organise un symposium à la conférence ISIET 2025 Thérapie Génique Perte Auditive SENS-401 Innovations Médicales Symposium Sensorion
BRIEF published on 04/16/2025 at 07:35, 1 year ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
PRESS RELEASE published on 04/16/2025 at 07:30, 1 year ago Inside Information / Other news releases Sensorion to host a symposium at ISIET's International Conference on Inner Ear Therapies in Marrakech, Morocco, on April 26, 2025, focusing on hearing loss innovation and gene therapies Sensorion Gene Therapies Symposium ISIET Inner Ear Therapies
PRESS RELEASE published on 04/16/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués Sensorion annonce un symposium lors de la conférence internationale ISIET sur les thérapies des maladies de l’oreille interne le 26 avril 2025 à Marrakech. Des interventions sur la perte auditive et thérapies géniques sont prévues Thérapies Géniques Sensorion Perte Auditive Symposium ISIET
Published on 05/04/2026 at 23:01, 50 minutes ago Copper Road Announces Closing of Non-Brokered Private Placement
Published on 05/04/2026 at 23:00, 51 minutes ago PJX Resources Adopting Semi-Annual Financial Reporting ("SAR")
Published on 05/04/2026 at 22:50, 1 hour 1 minute ago IBC Advanced Alloys Announces Amendment of Existing Credit Facility
Published on 05/04/2026 at 22:15, 1 hour 36 minutes ago Battery X Metals Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives
Published on 05/04/2026 at 22:05, 1 hour 46 minutes ago Unusual Machines to Announce First Quarter 2026 Financial Results and Provide Corporate Update
Published on 05/04/2026 at 21:05, 2 hours 46 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for Q1 2026 of €47.9 million and adjusted EBITDA of €7.6 million; forecast for the continuing operations unchanged
Published on 05/04/2026 at 20:02, 3 hours 48 minutes ago EQS-Adhoc: Rheinmetall AG: Preliminary operating margin in line with market expectation; revenue below market expectation despite growth due to delays into Q2 – 2026 full-year forecast reaffirmed
Published on 05/04/2026 at 19:30, 4 hours 21 minutes ago Shareholders approve all proposals – Dr Annelise Lüscher Hämmerli and Urs Simeon elected to the Board of Directors
Published on 05/04/2026 at 19:00, 4 hours 51 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 27 AVRIL 2026 au 01 MAI 2026
Published on 05/04/2026 at 19:00, 4 hours 51 minutes ago L’Assemblée générale 2026 approuve toutes les propositions du Conseil d’administration
Published on 05/04/2026 at 20:57, 2 hours 54 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 05/04/2026 at 20:57, 2 hours 54 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 05/04/2026 at 20:06, 3 hours 45 minutes ago Avril 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 05/04/2026 at 19:05, 4 hours 46 minutes ago CP -Mise en œuvre d’un contrat de liquidité avec INVEST SECURITIES
Published on 05/04/2026 at 18:19, 5 hours 32 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
